# Procter & Gamble Health Limited reported a 30% rise in Profit After Tax (PAT) for the financial year ended March 31, 2026.

*business · news · 2026-05-26 · scanx.trade*

## Key points

- Procter & Gamble Health changed its financial year end from June 30 to March 31 starting FY26.
- For FY26, PAT rose 30% to ₹327 crore and revenue increased 16% to ₹1,385 crore.
- Total dividend payout for FY26 is ₹205 per share, including a ₹160 interim and ₹45 final dividend.
- Board approved re-appointment of Mr. S. Madhavan as Independent Director for five years from November 15, 2026.
- New product launches included Livogen Iron Gummies and Neurobion Nerve Pain Relief Cream during FY26.

**Companies:** Procter & Gamble Health Limited
**Countries:** India

[Read the full story on scanx.trade](https://scanx.trade/stock-market-news/companies/p-g-health-fy26-net-profit-rises-39-5-to-32-691-lakh/41345268)

---

Canonical: https://newsio.io/n/19ef6167-972c-4dd7-a882-da083e8f4718/procter-gamble-health-limited-reported-a-30-rise-in-profit-after-tax-pat-for-the
Summarized by Newsio from scanx.trade. https://newsio.io/how-it-works